We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.
Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.
Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.
Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.
Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.
The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.
A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.
MSF first worked in Paraguay in 2010 and closed its projects in 2013.
MSF began working in Paraguay in 2010 to raise awareness of Chagas disease and improve diagnosis and treatment.
Working with the Ministry of Health, we piloted a better intervention strategy that brought diagnosis and treatment of Chagas closer to remote communities. The project was integrated into Boqueron regional hospital, two smaller hospitals, and 15 health centres and health posts.
In 2013, MSF left Paraguay but continued to support the health authorities with developing a national protocol for Chagas diagnosis and treatment.
MSF first worked in Paraguay in
Shortage of benznidazole leaves Chagas patients without treatment